ISSN: 1043-0342

Journal Home

Journal Guideline

Human Gene Therapy Q2 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human Gene Therapy is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 159. It has an SJR impact factor of 1,091 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,091.

Human Gene Therapy focuses its scope in these topics and keywords: gene, vector, cell, virus, type, human, expression, therapy, adenoassociated, skin, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (Q2) Molecular Biology (Q2) Molecular Medicine (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,091

SJR Impact factor

159

H Index

127

Total Docs (Last Year)

447

Total Docs (3 years)

6032

Total Refs

1437

Total Cites (3 years)

389

Citable Docs (3 years)

2.95

Cites/Doc (2 years)

47.5

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Brain Q2
Frontiers in Molecular Neuroscience Q2
Mitochondrion Q2
Developmental Biology Q2
Advances in Biological Regulation Q2

Compare this journals

Aims and Scope

Best articles by citations

Gene Transfer of Connexin43 into Skeletal Muscle

Heme Oxygenase 1 Mediates the Immunomodulatory and Antiapoptotic Effects of Interleukin 13 Gene TherapyIn VivoandIn Vitro

Improving Access to Intestinal Stem Cells as a Step Toward Intestinal Gene Transfer

Potential of Atelocollagen-Mediated Systemic Antisense Therapeutics for Inflammatory Disease

Low-Level Tyrosine Hydroxylase (TH) Expression Allows for the Generation of Stable TH+ Cell Lines of Human Neural Stem Cells

Electrotransfer of the Full-Length Dog Dystrophin into Mouse and Dystrophic Dog Muscles

Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients

In Vivo Gene Transfer into Muscle via Electro-Sonoporation

Combined Immunotherapy and Antiangiogenic Therapy of Cancer with Microencapsulated Cells

Nonionic Amphiphilic Block Copolymers Promote Gene Transfer to the Lung

Redox Regulation of Pancreatic Cancer Cell Growth: Role of Glutathione Peroxidase in the Suppression of the Malignant Phenotype

Transduction of Human Islets with Pseudotyped Lentiviral Vectors

SHOW MORE ARTICLES

Stimulation of Reparative Dentin Formation by Ex Vivo Gene Therapy Using Dental Pulp Stem Cells Electrotransfected with Growth/differentiation factor 11 (Gdf11)

Identification and Characterization of Novel Human Glioma-Specific Peptides to Potentiate Tumor-Specific Gene Delivery

Successful Gene Therapy via Intraarticular Injection of Adenovirus Vector Containing CTLA4IgG in a Murine Model of Type II Collagen-Induced Arthritis

Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model

Amphiphilic Block Copolymers Promote Gene Delivery In Vivo to Pathological Skeletal Muscles

Novel Bidirectional Vector Strategy for Amplification of Therapeutic and Reporter Gene Expression

"Dystrophin Expression in Muscle Following Gene Transfer with a Fully Deleted (""Gutted"") Adenovirus Is Markedly Improved by Trans-Acting Adenoviral Gene Products"

Effect of Intratracheal Adenoviral Vector Administration on Lung Development in Newborn Rats

Neurodegeneration Augments the Ability of Bone Marrow-Derived Mesenchymal Stem Cells to Fuse with Purkinje Neurons in Niemann-Pick Type C Mice

Modulation of Eomes Activity Alters the Size of the Developing Heart: Implications for In Utero Cardiac Gene Therapy

Intravenous Injection of Naked DNA Encoding Secreted flt3 Ligand Dramatically Increases the Number of Dendritic Cells and Natural Killer Cellsin Vivo

Curative Antitumor Immune Response Is Optimal with Tumor Irradiation Followed by Genetic Induction of Major Histocompatibility Complex Class I and Class II Molecules and Suppression of Ii Protein